Investing in human longevity
We are a seed and Series A VC with $37M under management, investing in companies that will allow us to live longer and healthier lives.
Learn more about the scienceor jump to the portfolio

Portfolio
Contact

Longevity entrepreneur? Send us a line!
Portfolio News
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
Unity Biotechnology, Inc. announces first patient tried in UBX0101 Phase 1 trial for osteoarthritis of the knee
Metacrine Completes $65 Million Series C Financing
Unity Biotech IPO Raises $85M to Test Drugs for Diseases of Aging